Letter to the Editor : Combined Intravenous and Intraarticular Tranexamic Acid Does Not Offer Additional Benefit Compared with Intraarticular Use Alone in Bilateral TKA: A Randomized Controlled Trial
| Errataetall: |
CommentOn: Clin Orthop Relat Res. 2020 Jan;478(1):45-54. - PMID 31498264 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:478 |
|---|---|
| Enthalten in: |
Clinical orthopaedics and related research - 478(2020), 4 vom: 01. Apr., Seite 909-911 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wu, Xiang-Dong [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
6T84R30KC1 |
|---|
| Anmerkungen: |
Date Completed 25.11.2020 Date Revised 05.10.2022 published: Print CommentOn: Clin Orthop Relat Res. 2020 Jan;478(1):45-54. - PMID 31498264 Citation Status MEDLINE |
|---|
| doi: |
10.1097/CORR.0000000000001158 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM306525992 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM306525992 | ||
| 003 | DE-627 | ||
| 005 | 20231225123546.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/CORR.0000000000001158 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1021.xml |
| 035 | |a (DE-627)NLM306525992 | ||
| 035 | |a (NLM)32058422 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wu, Xiang-Dong |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Letter to the Editor |b Combined Intravenous and Intraarticular Tranexamic Acid Does Not Offer Additional Benefit Compared with Intraarticular Use Alone in Bilateral TKA: A Randomized Controlled Trial |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.11.2020 | ||
| 500 | |a Date Revised 05.10.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: Clin Orthop Relat Res. 2020 Jan;478(1):45-54. - PMID 31498264 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Antifibrinolytic Agents |2 NLM | |
| 650 | 7 | |a Tranexamic Acid |2 NLM | |
| 650 | 7 | |a 6T84R30KC1 |2 NLM | |
| 700 | 1 | |a Wu, Di |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Yong |e verfasserin |4 aut | |
| 700 | 1 | |a Huang, Wei |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical orthopaedics and related research |d 1963 |g 478(2020), 4 vom: 01. Apr., Seite 909-911 |w (DE-627)NLM000002178 |x 1528-1132 |7 nnns |
| 773 | 1 | 8 | |g volume:478 |g year:2020 |g number:4 |g day:01 |g month:04 |g pages:909-911 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1097/CORR.0000000000001158 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 478 |j 2020 |e 4 |b 01 |c 04 |h 909-911 | ||